Lead strategy and deal execution for Oncology (and potentially Radiology) BD&L initiatives: sourcing, evaluation, negotiation, contracting and deal close; Own or co-lead transactions end-to-end, including business case development, valuation, term sheet negotiation, due diligence and transition to alliance management; Lead Integrated Deal Teams (IDTs), partnering with Scientific Licensing colleagues (SLO) where appropriate; Drive internal opportunity assessments - technical, clinical, commercial and financial - and synthesize findings for BU and executive decision-making; Negotiate directly with partner counterparts and shape creative deal structures to solve complex commercial, scientific and legal requirements; Present opportunity assessments and recommended approaches to leadership and senior governance committees to secure approvals for term sheet, diligence and contracting phases; Manage selected alliances to deliver on deal value and ensure effective partner governance and outcomes; Maintain and expand external networks across biotech, pharma, investors and ecosystem partners to proactively generate and evaluate opportunities; Execute Bayer's Open Innovation/ecosystem engagement strategy in the US and EU and collaborate closely with regional commercial teams to identify regional opportunities and alignment. Advanced degree (MS/MA/PhD or comparable) in Life Sciences, or degree in Business, Law, Finance, or related field; Proven track record of leading and closing complex biopharma deals; Strong negotiation and contracting experience (please include deal sheet with application); Deep understanding of pharmaceutical R&D, Oncology drug development and competitive landscape; Strong commercial acumen, including advising on valuation, deal structuring and business case development; Excellent analytical, communication and presentation skills; able to distill complex information and influence at executive levels; Demonstrated ability to lead cross-functional teams in a matrix environment and to drive timely decisions and outcomes; Ability to build trust and influence internal and external stakeholders across cultures and seniority levels; Willingness to travel up to 40%.